Justin J. McAnear - 16 Apr 2026 Form 4 Insider Report for Alamar Biosciences, Inc. (ALMR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Apr 2026, 20:33:02 UTC
Prior SEC filing
26 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Timothy White, Attorney-in-Fact

Key filing fact

Justin J. McAnear filed Form 4 for Alamar Biosciences, Inc. (ALMR) on 20 Apr 2026.

Key facts

  • This page summarizes Justin J. McAnear's Form 4 filing for Alamar Biosciences, Inc. (ALMR).
  • 4 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 20 Apr 2026, 20:33.

Change

  • Previous filing in this sequence was filed on 26 Aug 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001786386 Primary reporting owner

McAnear Justin J.

Relationship
Chief Financial Officer
Address
C/O ALAMAR BIOSCIENCES, INC., 47071 BAYSIDE PARKWAY, FREMONT
Signature
/s/ Timothy White, Attorney-in-Fact
Signature date
20 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALMR transaction

Common Stock

Award

Transaction value
Shares
+37,220
Change %
Price
$0.000000*
Shares after
37,220
Date
20 Apr 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALMR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+163,358
Change %
Price
$0.000000*
Shares after
163,358
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
163,358
Exercise price
$17.00
Footnotes
F2
ALMR transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
-570,719
Change %
-100%
Price
$0.000000*
Shares after
0
Date
20 Apr 2026
Ownership
Direct
Underlying class
Class B Common Stock
Underlying amount
570,719
Exercise price
$4.62
Footnotes
F3, F4
ALMR transaction Derivative

Stock Option (Right to Buy)

Other

Transaction value
Shares
+570,719
Change %
Price
$0.000000*
Shares after
570,719
Date
20 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
570,719
Exercise price
$4.62
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date.

Footnote F2

Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.

Footnote F3

Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock.

Footnote F4

Twenty-five percent of the shares subject to the option vest on October 13, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .